Table VI.
Comparison of serum indexes by The International Federation of Gynecology and Obstetrics staging in normal controls and patients with AC.
| Normal | Stage I AC | Normal vs. Stage I AC | Stage II AC | Normal vs. Stage II AC | Stage III/IV | Normal vs. AC (Stage III/IV) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Serum index | n | Mean ± SD | n | Mean ± SD | OR (95% CI) | P-value | n | Mean ± SD | OR (95% CI) | P-value | n | Mean ± SD | OR (95% CI) | P-value |
| ALP | 237 | 53.236±16.262 | 15 | 62.227±15.191 | 1.028 (1.001–1.055) | 0.038a | 6 | 75.400±38.388 | 1.042 (1.011–1.073) | 0.217 | 0 | 0 | N/A | N/A |
| Cholesterol | 388 | 4.645±0.823 | 12 | 5.223±0.960 | 2.178 (1.142–4.153) | 0.017a | 5 | 5.172±0.969 | 2.056 (0.767–5.512) | 0.156 | 1 | 6.100 | 5.071 (0.826–31.145) | 0.078 |
| TG | 388 | 1.105±0.526 | 12 | 1.794±1.130 | 2.798 (1.539–5.084) | 0.059 | 5 | 1.512±0.412 | 2.131 (0.858–5.290) | 0.086 | 1 | 1.650 | 2.305 (0.437–12.167) | 0.302 |
a
P<0.05. AC, cervical adenocarcinoma; ALP, alkaline phosphatase; TG, triglyceride; SD, standard deviation; OR, odds ratio; CI, confidence interval.